Citigroup Inc Vericel Corp Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Vericel Corp stock. As of the latest transaction made, Citigroup Inc holds 90,057 shares of VCEL stock, worth $4.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,057
Previous 64,847
38.88%
Holding current value
$4.17 Million
Previous $2.74 Million
80.54%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding VCEL
# of Institutions
293Shares Held
50.7MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$373 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$161 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$150 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$111 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$104 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.18B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...